Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis

Clinical Microbiology and Infection

Volumn 15, Issue 1, 2009, Pages 67-74

  Mastromarino, Paola ^a   Macchia, S ^a   Meggiorini, L ^a   Trinchieri, V ^a   Mosca, L ^a   Perluigi, M ^a   Midulla, C ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bacterial vaginosis; Lactobacilli; Probiotics; Vaginal microbiota; Vaginal polyamines

Indexed keywords

FLORISTA; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BEDTIME DOSAGE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GOOD CLINICAL PRACTICE; HUMAN; HUMAN TISSUE; LACTOBACILLUS BREVIS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS SALIVARIUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT RESPONSE; VAGINA FLORA; VAGINITIS;

BACTERIA (MICROORGANISMS); LACTOBACILLUS;

EID: 59349108821     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02112.x     Document Type: Article

References (43)

1. Cauci S, Driussi S, De Santo D et al. Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women. J Clin Invest 2002; 40: 2147-2152.
2. Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol 2007; 109: 114-120.
3. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005; 353: 1899-1911.
4. Hawes SE, Hillier SL, Benedetti J et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996; 174: 1058-1063.
5. Redondo-Lopez V, Cook RL, Sobel JD. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis 1990; 12: 856-872.
6. Aroutcheva A, Gariti D, Simon M et al. Defense factors of vaginal lactobacilli. Am J Obstet Gynecol 2001; 185: 375-379.
7. Valore EV, Park CH, Igreti SL, Ganz T. Antimicrobial components of vaginal fluid. Am J Obstet Gynecol 2002; 187: 561-568.
8. Klebanoff MA, Schwebke JR, Zhang J, Nansel TR, Yu KF, Andrews WW. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol 2004; 104: 267-272.
9. Cook RL, Redondo-Lopez V, Schmitt C, Meriwether C, Sobel JD. Clinical, microbiological, and biochemical factors in recurrent bacterial vaginosis. J Clin Microbiol 1992; 30: 870-877.
10. Wolrath H, Forsum U, Larsson PG, Borén H. Analysis of bacterial vaginosis-related amines in vaginal fluid by gas chromatography and mass spectrometry. J Clin Microbiol 2001; 39: 4026-4031.
11. Sobel JD. Vaginitis. N Engl J Med 1997; 337: 1896-1903.
12. Brand JM, Galask RP. Trimethylamine: The substance mainly responsible for the fishy odor often associated with bacterial vaginosis. Obstet Gynecol 1986; 63: 682-685.
13. Koumans EH, Markowitz LE, Hogan V. Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: A synthesis of data. Clin Infect Dis 2002; 35(suppl 2): S152-S172.
14. Harmanli OH, Cheng GY, Nyirjesy P, Chatwani A, Gaughan JP. Urinary tract infections in women with bacterial vaginosis. Obstet Gynecol 2000; 95: 710-712.
15. Hillebrand L, Harmanli OH, Whiteman V, Khandelwal M. Urinary tract infections in pregnant women with bacterial vaginosis. Am J Obstet Gynecol 2002; 186: 916-917.
16. Watts DH, Fazarri M, Minkoff H et al. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis 2005; 191: 1129-1139.
17. Martin HL, Richardson BA, Nyange PM et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180: 1863-1868.
18. Cherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003; 37: 319-325.
19. Ross SA, Novak Z, Ashrith G et al. Association between genital tract cytomegalovirus infection and bacterial vaginosis. J Infect Dis 2005; 192: 1727-1730.
20. Wiesenfeld H, Hillier S, Krohn MA, Landers D, Sweet R. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis 2003; 36: 663-668.
21. Cherpes TL, Melan MA, Kant JA, Cosentino LA, Meyn LA, Hillier SL. Genital tract shedding of Herpes simplex virus type 2 in women: Effects of hormonal contraception, bacterial vaginosis and vaginal group B Streptococcus colonization. Clin Infect Dis 2005; 40: 1422-1428.
22. Sha BE, Zariffard MR, Wang QJ et al. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis 2005; 191: 25-32.
23. Sobel JD, Ferris D, Schwebke J et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006; 194: 1283-1289.
24. Bayer AS, Chow AW, Concepcion N, Guze LB. Susceptibility of 40 lactobacilli to six antimicrobial agents with broad gram-positive anaerobic spectra. Antimicrob Agents Chemother 1978; 14: 720-722.
25. McLean NW, McGroarty JA. Growth inhibition of metronidazole-susceptible and metronidazole-resistant strains of Gardnerella vaginalis by lactobacilli in vitro. Appl Environ Microbiol 1996; 62: 1089-1092.
26. Beigi RH, Austin MN, Meyn LA, Krohn MA, Hillier SL. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 2004; 191: 1124-1129.
27. Sieber R, Dietz UT. Lactobacillus acidophilus and yogurt in the prevention and therapy of bacterial vaginosis. Int Dairy J 1998; 8: 599-607.
28. Falagas ME, Betsi GI, Athanasiou S. Probiotics for the treatment of women with bacterial vaginosis. Clin Microbiol Infect 2007; 13: 657-664.
29. Fredricsson B, Englund K, Weintraub L, Olund A, Nord CE. Bacterial vaginosis is not a simple ecological disorder. Gynecol Obstet Invest 1989; 28: 156-160.
30. Hallén A, Jarstrand C, Påhlson C. Treatment of bacterial vaginosis with lactobacilli. Sex Transm Dis 1992; 19: 146-148.
31. Reid G, Beuerman D, Heinemann C, Bruce EW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol 2001; 32: 37-41.
32. Reid G, Charbonneau D, Erb J et al. Oral use of L. rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: Randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003; 35: 131-134.
33. Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, Reid G. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect 2006; 8: 2772-2776.
34. Maggi L, Mastromarino P, Macchia S et al. Technological and biological evaluation of tablets containing different strains of lactobacilli for vaginal administration. Eur J Pharm Biopharm 2000; 50: 389-395.
35. Mastromarino P, Brigidi P, Macchia S et al. Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J Appl Microbiol 2002; 93: 884-893.
36. Massi M, Vitali B, Federici F, Matteuzzi D, Brigidi P. Identification method based on PCR combined with automated ribotyping for tracking probiotic Lactobacillus strains colonizing the human gut and vagina. J Appl Microbiol 2004; 96: 777-786.
37. Amsel R, Totten PA, Spiegel CA, Chen KCS, Eschenbach D, Holmes KK. Non specific vaginitis: Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74: 14-22.
38. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991; 29: 297-301.
39. Fu S, Zou X, Wang X, Liu X. Determination of polyamines in human prostate by high performance liquid chromatography with fluorescence detection. J Chromatogr B 1998; 709: 297-300.
40. Sobel J, Peipert JF, McGregor JA et al. Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis. Infect Dis Obstet Gynecol 2001; 9: 9-15.
41. Klebanoff MA, Hauth JC, MacPherson CA et al. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol 2004; 190: 363-370.
42. Schwebke JR. Asymptomatic bacterial vaginosis: Response to therapy. Am J Obstet Gynecol 2000; 183: 1434-1439.
43. Di Marzio L, Russo FP, D'Alò S et al. Apoptotic effects of selected strains of lactic acid bacteria on human T leukemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities. Nutr Cancer 2001; 40: 185-196.